Carmen Espejo Selected Research

Carmen Espejo Research Topics

Disease

29	Multiple Sclerosis 11/2022 - 02/2002
13	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 09/2002
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2009
5	Neuroinflammatory Diseases 01/2020 - 10/2006
4	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013 - 06/2005
1	COVID-19 04/2022
1	Relapsing-Remitting Multiple Sclerosis 12/2021
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Neoplasms (Cancer) 11/2019
1	Dysbiosis 01/2019
1	Infections 01/2019
1	Disease Progression 02/2018
1	Opportunistic Infections (Opportunistic Infection) 03/2015
1	Progressive Multifocal Leukoencephalopathy 03/2015
1	Alzheimer Disease (Alzheimer's Disease) 10/2006
1	Amyloid Plaque 10/2006

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2005
4	AutoantigensIBA 10/2018 - 05/2009
4	AntigensIBA 10/2018 - 02/2002
3	Oligoclonal BandsIBA 11/2022 - 01/2018
3	Natalizumab (Tysabri)FDA Link 04/2022 - 03/2015
3	Therapeutic UsesIBA 01/2021 - 01/2012
3	AntibodiesIBA 01/2020 - 01/2007
3	Interferon-betaIBA 01/2018 - 02/2009
3	Myelin-Oligodendrocyte GlycoproteinIBA 10/2017 - 06/2012
3	Semaphorins (Semaphorin)IBA 01/2017 - 03/2013
2	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 10/2020 - 01/2019
2	LipopolysaccharidesIBA 01/2020 - 01/2017
2	LipidsIBA 01/2020 - 03/2015
2	Peptides (Polypeptides)IBA 07/2019 - 10/2018
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2019 - 01/2018
2	MetallothioneinIBA 10/2006 - 06/2005
1	Immunoglobulins (Immunoglobulin)IBA 11/2022
1	Immunoglobulin G (IgG)IBA 11/2022
1	COVID-19 VaccinesIBA 01/2022
1	Cladribine FDA LinkGeneric 12/2021
1	2'-deoxyadenosineIBA 12/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	PyrinIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Neutralizing AntibodiesIBA 11/2019
1	Retinaldehyde (Retinal)IBA 07/2019
1	Ophthalmic Solutions (Eye Drops)IBA 07/2019
1	Bone Morphogenetic Protein 5IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Peptide LibraryIBA 10/2018
1	HLA-DRB3 Chains (HLA DRB3)IBA 10/2018
1	FucoseIBA 10/2018
1	Guanosine Diphosphate (GDP)IBA 10/2018
1	CytokinesIBA 10/2017
1	InterleukinsIBA 10/2017
1	Interleukin-23 (Interleukin 23)IBA 10/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2017
1	EndotoxinsIBA 01/2017
1	Isoantigens (Alloantigen)IBA 12/2016
1	Semaphorin-3AIBA 02/2016
1	ChitinasesIBA 10/2015
1	Immunoglobulin M (IgM)IBA 03/2015
1	heat-shock protein 70.1IBA 01/2014
1	delta proteinIBA 04/2013
1	LigandsIBA 04/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 09/2012
1	VaccinesIBA 06/2012
1	DNA VaccinesIBA 06/2012
1	A-Form DNA (A-DNA)IBA 06/2012
1	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2012
1	Toll-Like Receptor 4IBA 10/2011
1	InterferonsIBA 10/2011
1	Matrix Metalloproteinases (MMPs)IBA 02/2009
1	AntioxidantsIBA 06/2005
1	Interferon-gamma (Interferon, gamma)IBA 09/2002

Therapy/Procedure

7	Therapeutics 01/2020 - 02/2009
1	Treatment Delay 11/2020
1	Precision Medicine 01/2020
1	Immunotherapy 11/2019
1	Topical Administration 07/2019
1	Transplantation 12/2016
1	Immunomodulation 01/2012